Evidence map›Paper›PMID 39858555›Full record

ArticleGenes2024

Model Organisms in Aging Research: Evolution of Database Annotation and Ortholog Discovery.

Elizaveta Sarygina, Anna Kliuchnikova, Svetlana Tarbeeva, Ekaterina Ilgisonis, Elena Ponomarenko

Abstract read
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elizaveta SaryginaInstitute of Biomedical Chemistry, 119121 Moscow, Russia.ORCID 0000-0002-2261-2038
Anna KliuchnikovaInstitute of Biomedical Chemistry, 119121 Moscow, Russia.ORCID 0000-0001-9230-1238
Svetlana TarbeevaInstitute of Biomedical Chemistry, 119121 Moscow, Russia.
Ekaterina IlgisonisInstitute of Biomedical Chemistry, 119121 Moscow, Russia.
Elena PonomarenkoInstitute of Biomedical Chemistry, 119121 Moscow, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2024-643
6 · The paper itself

Abstract

backgroundThis study aims to analyze the exploration degree of popular model organisms by utilizing annotations from the UniProtKB (Swiss-Prot) knowledge base. The research focuses on understanding the genomic and post-genomic data of various organisms, particularly in relation to aging as an integral model for studying the molecular mechanisms underlying pathological processes and physiological states.

methodsHaving characterized the organisms by selected parameters (numbers of gene splice variants, post-translational modifications, etc.) using previously developed information models, we calculated proteome sizes: the number of possible proteoforms for each species. Our analysis also involved searching for orthologs of human aging genes within these model species.

resultsOur findings indicate that genomic and post-genomic data for more primitive species, such as bacteria and fungi, are more comprehensively characterized compared to other organisms. This is attributed to their experimental accessibility and simplicity. Additionally, we discovered that the genomes of the most studied model organisms allow for a detailed analysis of the aging process, revealing a greater number of orthologous genes related to aging.

conclusionsThe results highlight the importance of annotating the genomes of less-studied species to identify orthologs of marker genes associated with complex physiological processes, including aging. Species that potentially possess unique traits associated with longevity and resilience to age-related changes require comprehensive genomic studies.

Indexed as

AgingDatabases, GeneticMolecular Sequence AnnotationAnimalsHumansLongevityProteomeProteomeagingmodel organismproteoformstrend analysis

Identifiers

PMID39858555
PMCPMC11765380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.